172 related articles for article (PubMed ID: 2138899)
1. The beneficial effect of atrial natriuretic peptide on cyclosporine nephrotoxicity.
Capasso G; Rosati C; Ciani F; Giordano DR; Russo F; De Santo NG
Am J Hypertens; 1990 Mar; 3(3):204-10. PubMed ID: 2138899
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
Capasso G; Unwin R; Ciani F; Rizzo A; Russo F; Pica A; De Santo NG
Nephron; 2000 Nov; 86(3):298-305. PubMed ID: 11096287
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of atrial natriuretic factor on cisplatin-induced acute renal failure in the rat.
Capasso G; Anastasio P; Giordano D; Albarano L; De Santo NG
Am J Nephrol; 1987; 7(3):228-34. PubMed ID: 2957916
[TBL] [Abstract][Full Text] [Related]
4. Effects of atrial natriuretic peptide on urinary kallikrein excretion and renal function in rats.
Lòpez C; Jimenez W; Arroyo V; La Villa G; Martinez-Pardo A; Gaya J; Rivera F
Eur J Pharmacol; 1989 Sep; 168(1):1-6. PubMed ID: 2531092
[TBL] [Abstract][Full Text] [Related]
5. Renal and hormonal effects and tolerance of an ANP analogue in healthy man.
Eiskjaer H; Schmiegelow M; Jespersen B; Tietze IN; Jensen JD; Sørensen SS; Thomsen K; Pedersen EB
Eur J Clin Pharmacol; 1991; 41(6):547-54. PubMed ID: 1840038
[TBL] [Abstract][Full Text] [Related]
6. [Effect of recombinant atrial natriuretic peptide (r-ANP) on ischemic and cyclosporine-induced kidney damage in rats].
Yoshida K; Kagebayashi Y; Saka T; Yoneda T; Tani M; Ota M; Okajima E; Ozono S; Hirao Y; Okajima E
Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):123-9. PubMed ID: 8139144
[TBL] [Abstract][Full Text] [Related]
7. Four-hour atrial natriuretic peptide infusion in conscious rats: effects on urinary volume, sodium, and cyclic GMP.
Campbell HT; Lightfoot BO; Sklar AH
Proc Soc Exp Biol Med; 1988 Dec; 189(3):317-24. PubMed ID: 2849771
[TBL] [Abstract][Full Text] [Related]
8. Amplification by atrial natriuretic peptide of the haemodynamic and renal responses to an acute volumic stress in the rat.
Caron N; Simon F; Plennevaux F; Michel A; Kramp R
Clin Exp Pharmacol Physiol; 1999 Apr; 26(4):315-22. PubMed ID: 10225142
[TBL] [Abstract][Full Text] [Related]
9. Effect of short-term cyclosporine A administration on urinary acidification.
Batlle DC; Gutterman C; Tarka J; Prasad R
Clin Nephrol; 1986; 25 Suppl 1():S62-9. PubMed ID: 3011339
[TBL] [Abstract][Full Text] [Related]
10. Norepinephrine-induced acute renal failure: beneficial effects of atrial natriuretic factor.
Schafferhans K; Heidbreder E; Grimm D; Heidland A
Nephron; 1986; 44(3):240-4. PubMed ID: 2946967
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic peptide and dopamine in a rat model of ischemic acute renal failure.
Conger JD; Falk SA; Yuan BH; Schrier RW
Kidney Int; 1989 May; 35(5):1126-32. PubMed ID: 2528019
[TBL] [Abstract][Full Text] [Related]
12. Long-term infusion of atrial natriuretic peptide (ANP) improves renal blood flow and glomerular filtration rate in clinical acute renal failure.
Swärd K; Valson F; Ricksten SE
Acta Anaesthesiol Scand; 2001 May; 45(5):536-42. PubMed ID: 11309000
[TBL] [Abstract][Full Text] [Related]
13. Effect of atrial natriuretic peptide on the release of rat renal kallikrein.
Klein HG; Schöneck V; Obika LF; Odigie P; Angchanpen P; Marin-Grez M
Miner Electrolyte Metab; 1989; 15(3):130-6. PubMed ID: 2524641
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane receptor blockade improves cyclosporine nephrotoxicity in rats.
Spurney RF; Mayros SD; Collins D; Ruiz P; Klotman PE; Coffman T
Prostaglandins; 1990 Feb; 39(2):135-46. PubMed ID: 2138344
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of intravenous cyclosporine on blood pressure, renal hemodynamics, and urine prostaglandin production of healthy humans.
Weir MR; Klassen DK; Shen SY; Sullivan D; Buddemeyer EU; Handwerger BS
Transplantation; 1990 Jan; 49(1):41-7. PubMed ID: 2301025
[TBL] [Abstract][Full Text] [Related]
16. Effects of atrial natriuretic peptide on renal function after cardiac surgery and in cyclosporine-treated heart transplant recipients.
Valsson F; Ricksten SE; Hedner T; Zäll S; William-Olsson EB; Lundin S
J Cardiothorac Vasc Anesth; 1994 Aug; 8(4):425-30. PubMed ID: 7948799
[TBL] [Abstract][Full Text] [Related]
17. The dopamine receptor antagonist haloperidol blocks natriuretic but not hypotensive effects of the atrial natriuretic factor.
Hansell P; Fasching A; Sjöquist M; Andén NE; Ulfendahl HR
Acta Physiol Scand; 1987 Jul; 130(3):401-7. PubMed ID: 2957892
[TBL] [Abstract][Full Text] [Related]
18. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
[TBL] [Abstract][Full Text] [Related]
19. Effects of atrial natriuretic peptide on glycerol induced acute renal failure in the rat.
Seki G; Suzuki K; Nonaka T; Nosaka K; Taniguchi S; Aizawa C; Kurokawa K
Jpn Heart J; 1992 May; 33(3):383-93. PubMed ID: 1387917
[TBL] [Abstract][Full Text] [Related]
20. Restoration of renal responsiveness to atrial natriuretic peptide in experimental nephrotic syndrome by albumin infusion.
Abassi Z; Weissman I; Karram T; Goltsman I; Hoffman A; Better OS; Winaver J
Am J Nephrol; 2013; 38(4):292-9. PubMed ID: 24080549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
